| Literature DB >> 29410419 |
Ilya R Akberdin1,2, Merlin Thompson1, Richard Hamilton1, Nalini Desai3, Danny Alexander3, Calvin A Henard4, Michael T Guarnieri4, Marina G Kalyuzhnaya5.
Abstract
Biological methane utilization, one of the main sinks of the greenhouse gas in nature, represents an attractive platform for production of fuels and value-added chemicals. Despite the progress made in our understanding of the individual parts of methane utilization, our knowledge of how the whole-cell metabolic network is organized and coordinated is limited. Attractive growth and methane-conversion rates, a complete and expert-annotated genome sequence, as well as large enzymatic, 13C-labeling, and transcriptomic datasets make Methylomicrobium alcaliphilum 20ZR an exceptional model system for investigating methane utilization networks. Here we present a comprehensive metabolic framework of methane and methanol utilization in M. alcaliphilum 20ZR. A set of novel metabolic reactions governing carbon distribution across central pathways in methanotrophic bacteria was predicted by in-silico simulations and confirmed by global non-targeted metabolomics and enzymatic evidences. Our data highlight the importance of substitution of ATP-linked steps with PPi-dependent reactions and support the presence of a carbon shunt from acetyl-CoA to the pentose-phosphate pathway and highly branched TCA cycle. The diverged TCA reactions promote balance between anabolic reactions and redox demands. The computational framework of C1-metabolism in methanotrophic bacteria can represent an efficient tool for metabolic engineering or ecosystem modeling.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29410419 PMCID: PMC5802761 DOI: 10.1038/s41598-018-20574-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Biomass composition and growth parameters of Methylomicrobium alcaliphilum 20Z. *CO2 production rates are below expected due to high pH of the growth medium.
| Compound | % | SD | mmol/g DCW biomass | Organism source | Reference |
|---|---|---|---|---|---|
|
|
|
| |||
| Alanine | 0.366 |
| This study | ||
| Arginine | 0.149 | -“- | -“- | ||
| Asparagine | 0.119 | -“- | -“- | ||
| Aspartate | 0.409 | -“- | -“- | ||
| Cysteine | 0.024 | -“- | -“- | ||
| Glutamate | 0.487 | -“- | -“- | ||
| Glutamine | 0.15 | -“- | -“- | ||
| Histidine | 0.078 | -“- | -“- | ||
| Glycine | 0.339 | -“- | -“- | ||
| Isoleucine | 0.203 | -“- | -“- | ||
| Leucine | 0.332 | -“- | -“- | ||
| Lysine | 0.182 | -“- | -“- | ||
| Methionine | 0.093 | -“- | -“- | ||
| Phenylalanine | 0.171 | -“- | -“- | ||
| Proline | 0.161 | -“- | -“- | ||
| Serine | 0.194 | -“- | -“- | ||
| Threonine | 0.229 | -“- | -“- | ||
| Tryptophan | 0.072 | -“- | -“- | ||
| Tyrosine | 0.111 | -“- | -“- | ||
| Valine | 0.278 | -“- | -“- | ||
|
|
|
| 0.106 | -“- | -“- |
|
|
|
| |||
|
| |||||
| C14 (myristate) | 0.010 |
| -“- | ||
| C15 (pentadecylic acid) | 0.002 | -“- | -“- | ||
| C16 (palmitate) | 0.329 | -“- | -“- | ||
| C18 (stearate) | 0.002 | -“- | -“- | ||
| Phosphatidylserine (1%)* | 0.002 | -“- |
[ | ||
| Phosphatidylethanolamine (50%)* | 0.086 | -“- | -“- | ||
| Dipalmitoyl phosphatidate (4)* | 0.007 | -“- | -“- | ||
| Cardiolipin (11)* | 0.019 | -“- | -“- | ||
| Phosphatidylglycerol (34)* | 0.059 | -“- | -“- | ||
|
|
| ||||
| tetrahymanol | 0.025 |
|
[ | ||
| aminotriol (III), 65% of BHP | 0.008 | -“- |
[ | ||
| 3-Me-aminotriol, 31% BHP | 0.003 | -“- | -“- | ||
| aminotetrol and 3-Me-aminotetrol, <3% BHP | -“- | -“- | 0.001 | ||
|
|
| — | |||
| Ribulose-5-phosphate/Ribose-5-phosphate | 0.001 | 16 | |||
| Fructose-1, 6-bisphosphate | 0.001 | -“- | -“- | ||
| Fructose-6-phosphate | 0.003 | -“- | -“- | ||
| Glucose-6-phosphate | 0.002 | -“- | -“- | ||
| Glyceraldehyde-3-phosphate/Dihydroxyacetone | 0.003 | -“- | -“- | ||
| 6-Phosphogluconic acid | 0.00015 | -“- | -“- | ||
| 2-dehydro-3-deoxy-phosphogluconate | 0.000003 | -“- | -“- | ||
| Phosphoglycerate | 0.006 | -“- | -“- | ||
| Phosphoenolpyruvate | 0.005 | -“- | -“- | ||
| Pyruvate | 0.015 | -“- | -“- | ||
| Acetyl-CoA | 0.0001 | -“- | -“- | ||
| Succinate | 0.002 | -“- | -“- | ||
| Malate | 0.004 | -“- | -“- | ||
| Fumarate | 0.001 | -“- | -“- | ||
| Citrate | 0.001 | -“- | -“- | ||
| Glycerate | 0.001 | -“- | -“- | ||
| ATP | 0.005 |
|
[ | ||
| ADP | 0.002 |
[ | |||
| AMP | 0.001 | -“- | |||
| NAD | 0.002 | -“- | |||
| NADH | 0.002 | -“- | |||
| NADP | 0.001 | -“- | |||
| NADPH | 0.001 | -“- | |||
| polyP (PPi) | 0.029 |
|
[ | ||
|
| |||||
| Cytochrome c | 0.00036 |
|
[ | ||
| B12 | 0.000000063 | -“- |
[ | ||
| Ubiquinol-8 | 0.00022 | Assumption |
[ | ||
| Protoheme | 0.00022 | Assumption | -“- | ||
| coenzyme-A | 0.00022 | Assumption | -“- | ||
| FMN | 0.00022 | Assumption | -“- | ||
| FMNH2 | 0.00022 | Assumption | -“- | ||
| FAD | 0.00022 | Assumption | -“- | ||
| SAM | 0.00022 | Assumption | -“- | ||
| Glutathione | 0.00022 | Assumption | -“- | ||
|
|
| 0.2 | |||
| Mannose | 0.002 |
[ | |||
| Ramnose | 0.0002 | -“- | -“- | ||
| Glycogen |
| 1.4 | 0.448 | -“- | This study |
| Sucrose |
| 0.2 | 0.026 | -“- |
[ |
| Ribose | 0.036 | -“- |
[ | ||
| Maltose | 0.008 | -“- | -“- | ||
| Arabinose | 0.022 | -“- | -“- | ||
| Galactose | 0.005 | -“- | -“- | ||
|
| |||||
| Peptidoglycan |
| - | 0.053 | Assumed as in |
[ |
| LPS (lipid IVA and KDO) |
| - | 0.002 | -“- | -“- |
|
|
|
| This study | ||
| ATP | 0.050 |
| -“- | ||
| UTP | 0.050 | -“- | -“- | ||
| CTP | 0.047 | -“- | -“- | ||
| GTP | 0.047 | -“- | -“- | ||
|
|
|
| This study | ||
| dATP | 0.0021 |
| -“- | ||
| dTTP | 0.0021 | -“- | -“- | ||
| dCTP | 0.0020 | -“- | -“- | ||
| dGTP | 0.0020 | -“- | -“- | ||
|
|
| Assumed as in |
[ | ||
|
|
|
| |||
| 3-PG (balance) | 1.8 | 0.010 | |||
|
|
| ||||
|
| |||||
|
| 44.9 | 2.6 |
| This study | |
|
| 8.1 | 2.4 | -“- | -“- | |
|
| 6.8 | 0.1 | -“- | -“- | |
|
| -“- | ||||
| Formate | 0.7 |
| -“- | ||
| Acetate | 0.02 | -“- | -“- | ||
| Lactate | 0.004 | -“- | -“- | ||
| EPS |
|
| -“- | -“- | |
| DCW (% WCW) | 25 ± 3.4 | ||||
|
| |||||
|
| |||||
| Methane Uptake (mmol g CDW−1 h−1) | 11.7 ± 0.14 | This study | |||
| Oxygen Uptake (mmol g CDW−1 h−1) | 14.7 ± 0.9 | -“- | |||
| O2/CH4 Uptake Ratio | 1.25 ± 0.06 | -“- | |||
| CO2 production (mmol g CDW−1 h−1)* | 0.37 ± 0.05 | -“- | |||
| Specific Growth Rate (h−1) | 0.12 ± 0.01 | -“- | |||
|
| |||||
| Methane Uptake (mmol g CDW−1 h−1) | 18.6 ± 1.4 | This study | |||
| Oxygen Uptake (mmol g CDW−1 h−1) | 24.4 ± 2.1 | -“- | |||
| O2:CH4 Uptake Ratio | 1.31 ± 0.07 | -“- | |||
| Specific Growth Rate (h−1) | 0.14 ± 0.02 | -“- | |||
Accumulation of excreted organic acids (mg g−1 DCW) by M.alcaliphilum 20ZR grown in batch culture with or without sodium tungsten (0.07 mg L−1).
| Compound | −Na2WO4 | +Na2WO4 |
|---|---|---|
| Formate | 45.8 ± 1.3 | 2.4 ± 0.9 |
| Acetate | 2.4 ± 0.2 | 2.0 ± 0.1 |
| Lactate | ND | trace |
| Succinate | ND | trace |
| Pyruvate | ND | ND |
| Citrate | ND | ND |
Summary of kinetic parameters for enzymes from central metabolic pathways in M.alcaliphilum 20Z(R).
| Enzyme | Cofactor | Enzyme activity (or Vmax) nmol min−1 mg protein−1 | Km/Ks (mM) | References |
|---|---|---|---|---|
| Methane monooxygenase (pMMO) | whole cells assay | 120 ± 40 |
[ | |
| Methanol dehydrogenase | PMS/Ca | 230 ± 10 | -“- | |
| Formate dehydrogenase | NAD+ | 132 ± 7 | -“- | |
| NADH-dehydrogenase (with 100 mM NaCl) | NADH | 454 ± 50 |
[ | |
| NADH-dehydrogenase (without NaCl) | NADH | 383 ± 80 | -“- | |
| ATPase | ADP | 8.6 ± 0.4 | -“- | |
| Hydroxypyruvate reductase* | NADPH | 41 ± 2 |
[ | |
| NADH | 26 ± 7 | -“- | ||
| Serine-glyoxylate aminotransferase, | ND |
[ | ||
| Glucokinase* | ATP | 217 ± 8 | 0.32 |
[ |
| 3-Hexulose phosphate synthase* | Ru5P | 172 ± 9 | 0.13 |
[ |
| Phosphoglucose isomerase | 32 ± 2 | -“- | ||
| 6-Phoshofructokinase* | F6P/PPi | 577 ± 60 | 0.64 |
[ |
| F6P/ATP | ND | -“- | ||
| FBP/PPi | 805 ± 80 | 0.095 | -“- | |
| Glucose-6-phosphate dehydrogenase | NAD+ | 23 ± 2 |
[ | |
| NADP+ | 34 ± 2 | -“- | ||
| 6-Phosphogluconate dehydrogenase | NADP+ | 32 ± 2 | -“- | |
| NAD+ | 12 ± 1 | -“- | ||
| Fructose-1,6-bisphosphate aldolase | 35 ± 2 |
[ | ||
| KDPG aldolase | 62 ± 3 | -“- | ||
| Enolase | 10 ± 1 | -“- | ||
| Fructokinase | 2.5 |
[ | ||
| Acetate kinase* | ADP | 1290 ± 31 | 5.6 |
[ |
| Phosphoketolase | TPP | 0.11 ± 0.02 | This study | |
| Pyruvate dehydrogenase | NAD+ | 120 ± 20 | -“- | |
| 2-Oxoglutarate dehydrogenase | NAD+ | N.D. | -“- | |
| Succinate semiladehyde dehydrogenase | NADP | 80 ± 17.4 | -“- | |
| Glutamate decarboxylase | NAD+ | 7.4 ± 1.1 | -“- | |
| Pyruvate kinase* | ADP | 200 ± 12* |
[ | |
| Citrate synthase | 6 ± 0.5 |
[ | ||
| Isocitrate dehydrogenase | NAD+ | ND | -“- | |
| NADP+ | 11 ± 1 | -“- | ||
| Malate dehydrogenase* | Malate (NAD+) | 1500 ± 150 | 0.11 (0.45) |
[ |
| Oxaloacetate (NADH) | 2100 ± 200 | 0.34 (0.025) | -“- | |
| Malate lyase | ATP, CoA | ND |
[ | |
| Glutamate dehydrogenase | NADH | 4 ± 0.5 | -“- | |
| NADPH | 3 ± 0.2 | -“- | ||
| Alanine dehydrogenase | NADPH | ND | -“- | |
| NADH | 2 ± 0.1 | -“- | ||
| Glutamate synthase | NADPH | 14 ± 1 | -“- | |
| Glutamine synthetase | Mn2+, ATP | 204 ± 10 | -“- |
*Purified enzyme.
Figure 1Central metabolic pathways of methane (A) and methanol (B) utilization in Methylomicrobium alcaliphilum 20ZR and results of FBA analyses. Red circles indicate input substrates (CH4, O2, or CH3OH), White circles with red outlines indicate excreted compounds (CO2 and acetate); thickness of arrow represents predicted value of the corresponding flux via the reaction (solid arrow) or metabolic pathway (dotted arrows); (C,D) 3D plots of comparative analysis of metabolic profiling versus predicted flux ratios between the same growth conditions (axis X – model rank; axis Y – metabolomics rank; axis Z – metabolic pathway that a compound belongs to). (C) Comparison of results for complete TCA cycle (Spearman’s index equals to 0.9, p-value = 2.7E-24); (D) Comparisons of results for branched TCA cycle and reverse phosphoketolase reaction (R = 0.99, p-value = 2E-55).
In silico predictions for different metabolic arrangements of methane utilization.
| Network | O2:CH4 | CO2 production (mmol g CDW−1h−1) | growth rate (h−1) |
|---|---|---|---|
| Source of electrons | |||
| Cytochrome cL | 1.2 | 5.2 | 0.146 |
| Ubiquinol | 1.50 | 7.7 | 0.09 |
| Initial network* | 1.2 | 5.2 | 0.146 |
| CO2 fixation via PEPCK | 1.2 | 5.2 | 0.147 |
| PPi-reactions (PFK, PEPCK, PPDK, PPi-ase) | 1.19 | 5.1 | 0.149 |
| Biosynthesis as a sole source of PPi (without PPiase) | 1.21 | 5.3 | 0.145 |
| Reversible PPK | 1.18 | 5.1 | 0.15 |
| Branched TCA | 1.18 | 5.1 | 0.15 |
| Fermentation mode (without ATPase) | 1.02 | 1.5 | 0.06 |
|
|
|
|
|
| Experimental data |
|
|
|
*Methane uptake is set to 11.7 mmol g CDW−1h−1; ** Oxygen uptake is set to 14.7 mmol g CDW−1h−1.
Figure 2Experimentally measured (dots) and predicted growth rates for different CH4 consumption rates at different level of ATP maintenance. Axis X: values of growth rate (h−1); Axis Y: CH4 consumption rates (mmol g DCW−1 h−1).
Figure 3Contribution of different sources of redox for methane utilization depending on O2:CH4 ratio. The height of the colored bar reflects the biomass production or percentage of the carbon flux a specific electron donor proportionally to 100% biomass at the particular value of O2:CH4 ratio.